Companies /Healthcare

BioAge Labs, Inc

NASDAQ: BIOA Drug Manufacturers - Specialty & Generic
$8.49
▼ $0.16 (−1.85%) today
Markets closed · 3:56am ET
Today · % change

Fundamentals

Market Cap
$397.0M
Revenue (TTM)
$10.4M
EPS (TTM)
$-2.25
52-Week Range
$5 – $26
Street Target
$35.62

About BioAge Labs

BioAge Labs, Inc. is a pioneering biotechnology firm based in Montreal, Canada, dedicated to developing therapeutics that enhance healthspan and longevity through advanced research in aging biology. By harnessing innovative insights into the mechanisms of aging, the company focuses on creating targeted treatments for age-related diseases, thereby playing a crucial role in the geriatric healthcare landscape. With a commitment to scientific rigor and collaboration with top-tier research institutions, BioAge is well-positioned to address the significant healthcare challenges posed by aging populations, ultimately striving to improve quality of life and health outcomes globally.

BIOA Coverage